TerminatedNo phase
New Horizons for the Treatment of Cardiomyopathy in Children
Reason given: lack of necessary equipment
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Damascus University
- Trial code
- NCT04893629
- Record updated
- 20 February 2025
- Original description
Collecting mono nuclear cells from the patient's blood after a course of granulocyte stimulation then injecting them into the weak heart muscle measuring the heart function at the beginning and after 2.4.6 months to assess the improvement due to this procedure, by comparing these patients to patients with the same condition treated the classic way.Read full original descriptionShow less
The Effectiveness of Autologous Mono Nuclear Cells in the Treatment of Dilated Cardiomyopathy in Children
Collecting mono nuclear cells from the patient's blood after a course of granulocyte stimulation then injecting them into the weak heart muscle measuring the heart function at the beginning and after 2.4.6 months to assess the improvement due to this procedure, by comparing these patients to patients with the same condition treated the classic way.
Inclusion: Dilated cardiomyopathy diagnosed and treated at least 6 mo. Ago; LVEF less than 40%; Use of I.V inotropes.
Exclusion: Acute infection; Severe organ failure (other than the heart).